Olaparib
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 8aca7953-121c-4bc4-bc4b-c3dea9d035ed | Product name | 1 | 20171006 |
| 74743eac-fb51-4dac-af6a-4c1391f918c9 | Product name | 1 | 20150225 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73309-165-01 | Olaparib | 10 g in 1 JAR | POWDER | 10 | 2 | |
| 73309-165-02 | Olaparib | 100 g in 1 JAR | POWDER | 100 | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 73309-165 | 73309-165-01, 73309-165-02 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| OLAPARIB | WOH1JD9AR8 | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lynparza | OLAPARIB | AstraZeneca Pharmaceuticals LP | 741ff3e3-dc1a-45a6-84e5-2481b27131aa | 2025-07-10 | Warnings, Adverse reactions | OLAPARIB |
Adverse event summaries are temporarily unavailable. Other product information remains available.